title: In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.
abstract: EPA has been clinically shown to reduce muscle wasting during cancer cachexia. This study investigates whether curcumin or green tea extract (GTE) enhances the ability of low doses of eicosapentaenoic acid (EPA) to reduce loss of muscle protein in an in vitro model. A low dose of EPA with minimal anti-cachectic activity was chosen to evaluate any potential synergistic effect with curcumin or GTE. Depression of protein synthesis and increase in degradation was determined in C2C12 myotubes in response to tumour necrosis factor-α (TNF-α) and proteolysis-inducing factor (PIF). EPA (50 μM) or curcumin (10 μg ml(-1)) alone had little effect on protein degradation caused by PIF but the combination produced complete inhibition, as did the combination with GTE (10 μg ml(-1)). In response to TNF-α (25 ng ml(-1))-induced protein degradation, EPA had a small, but not significant effect on protein degradation; however, when curcumin and GTE were combined with EPA, the effect was enhanced. EPA completely attenuated the depression of protein synthesis caused by TNF-α, but not that caused by PIF. The combination of EPA with curcumin produced a significant increase in protein synthesis to both agents. GTE alone or in combination with EPA had no effect on the depression of protein synthesis by TNF-α, but did significantly increase protein synthesis in PIF-treated cells. Both TNF-α and PIF significantly reduced myotube diameter from 17 to 13 μm for TNF-α (23.5%) and 15 μm (11.8%) for PIF However the triple combination of EPA, curcumin and GTE returned diameters to values not significantly different from the control. These results suggest that either curcumin or GTE or the combination could enhance the anti-catabolic effect of EPA on lean body mass.
authors.affiliation: Nutritional Biomedicine, School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK. k.a.mirza@aston.ac.uk.
authors.forename: Kamran A
authors.initials: KA
authors.lastname: Mirza
authors.affiliation: Abbott Nutrition, Research & Development, Columbus, OH, USA.
authors.forename: Menghua
authors.initials: M
authors.lastname: Luo
authors.affiliation: Abbott Nutrition, Research & Development, Columbus, OH, USA.
authors.forename: Suzette
authors.initials: S
authors.lastname: Pereira
authors.affiliation: Abbott Nutrition, Research & Development, Columbus, OH, USA.
authors.forename: Anne
authors.initials: A
authors.lastname: Voss
authors.affiliation: Abbott Nutrition, Research & Development, Columbus, OH, USA.
authors.forename: Tapas
authors.initials: T
authors.lastname: Das
authors.affiliation: Nutritional Biomedicine, School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Tisdale
mesh_terms: D000818:Animals; D003474:Curcumin / Q000008:administration & dosage*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D006801:Humans; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009133:Muscular Atrophy / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010936:Plant Extracts / Q000008:administration & dosage* / Q000737:chemistry; D011509:Proteoglycans / Q000008:administration & dosage; D059748:Proteolysis / Q000187:drug effects; D013662:Tea / Q000737:chemistry; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
chemical_list: D010936:Plant Extracts; D011509:Proteoglycans; D013662:Tea; D014409:Tumor Necrosis Factor-alpha; C042057:proteolysis-inducing peptide; D015118:Eicosapentaenoic Acid; D003474:Curcumin
keywords: Curcumin; EPA; Green tea extract; Muscle protein atrophy